If you are an Ochsner provider and need assistance with this site please email
[email protected]
.
ScholarlyWork@Ochsner
Toggle navigation
Browse
Home
People
Organizations
Research Areas
Publications
Capability Map
Melanoma Research
Journal
Overview
Identity
View All
Overview
Publication venue for
Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB-IVM1c melanoma
. 28:44-51.
2018
Identity
International Standard Serial Number (ISSN)
0960-8931
